Page last updated: 2024-08-17

ethinyl estradiol and Cardiovascular Diseases

ethinyl estradiol has been researched along with Cardiovascular Diseases in 78 studies

Research

Studies (78)

Timeframe	Studies, this research(%)	All Research%
pre-1990	24 (30.77)	18.7374
1990's	17 (21.79)	18.2507
2000's	15 (19.23)	29.6817
2010's	22 (28.21)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Michael, OS; Olatunji, LA	1
Dickins, M; Ezuruike, U; Gardner, I; Humphries, H; Neuhoff, S; Rowland Yeo, K	1
Bodur, S; Dundar, O; Kanat-Pektas, M; Kinci, MF; Tutuncu, L	1
Bender, JR; Leone, CA; Stachenfeld, NS; Steele, FE; Taylor, HS; Usselman, CW; Yarovinsky, TO	1
Shapiro, S	1
Apa, R; Ciardulli, A; Cosentino, N; Crea, F; Familiari, A; Lanzone, A; Liuzzo, G; Martinez, D; Morciano, A; Moro, F; Niccoli, G; Palla, C; Sagnella, F; Scarinci, E; Tritarelli, A; Tropea, A	1
Ambrosio, D; Cerreto, FV; De Franciscis, P; Labriola, D; Leo, S; Luisi, A; Mainini, G; Russo, C; Santangelo, F; Torella, M	1
Borghi, C; Cicero, AF; Grandi, E; Morbini, M; Parini, A; Reggi, A; Rosticci, M	1
Aksoy, A; Carlioglu, A; Gozukara, I; Kabil Kucur, S; Kamalak, Z; Keskin, H; Uludag, EU	1
El-Haggar, SM; Mostafa, TM	1
Black, A; Dunn, S; Rotermann, M	1
Dinger, J; Heinemann, K; Möhner, S	1
Bottiglieri, P; Colao, A; Colarieti, G; Giallauria, F; Muscogiuri, G; Orio, F; Palomba, S; Predotti, P; Savastano, S; Tafuri, D	1
Goel, N; Priya, K; Rajaram, S	1
Davenport, ML	1
Malek-Khosravi, S	1
Akcay, A; Bavbek, N; Gumus, II; Karakurt, F; Kargili, A; Koca, C; Kosar, A; Ozbek, M; Selcoki, Y	1
Kaplan, PF; Meendering, JR; Miller, NP; Minson, CT; Torgrimson, BN	1
Battaglia, C; Busacchi, P; Fabbri, R; Facchinetti, F; Mancini, F; Persico, N; Venturoli, S	1
Assmann, A; Bardenheuer, K; Dinger, JC	1
Fruzzetti, F; Gambacciani, M; Genazzani, AR; Lazzarini, V; Parrini, D; Perini, D	1
Weisberg, E	1
Akdeniz, B; Gode, F; Karagoz, C; Posaci, C; Saatli, B; Secil, M; Uysal, D	1
Arslanian, S; Lee, S; Sutton-Tyrrell, K; Tfayli, H; Ulnach, JW	1
de Sá, MF; dos Reis, RM; Fernandes, JB; Ferriani, RA; Martins, WP; Soares, GM; Vieira, CS	1
Cerda, A; da Silva, E; Hirata, MH; Hirata, RD; Kunz, VC; Rebelo, AC; Silva de Sá, MF; Tamburus, NY; Verlengia, R	1
Arangino, S; Cagnacci, A; Ferrari, S; Napolitano, A; Piacenti, I; Volpe, A	1
Montgomery Rice, V	1
WESTON, TE	1
Merz, WE	1
Morin-Papunen, LC; Rautio, K; Ruokonen, A; Tapanainen, JS	1
Alvarez-Blasco, F; Botella-Carretero, JI; Escobar-Morreale, HF; Lasunción, MA; Luque-Ramírez, M; Martínez-Bermejo, E	1
Khalil, RA; Koledova, VV	1
Kuhl, H; Wiegratz, I	1
Brook, RD; Duvernoy, CS; Kehrer, C; Kim, HM; Rose, PA	1
Goldzieher, JW	1
Christie, T	1
Guillebaud, J	1
Haspels, AA	1
Agardh, CD; Gustafson, A; Lundgren, R; Nilsson-Ehle, P	1
Kay, CR	1
Greenberg, G; Meade, TW; Thompson, SG	1
Gurewich, V; Jick, H; Jick, SS; Myers, MW; Vasilakis, C	1
Crook, D; Devenport, M; Godsland, IF; Wynn, V	1
Ciuffetti, G; Coata, G; Cosmi, EV; Di Renzo, GC; Lombardini, R; Ventura, F	1
Urdinola, J	1
Denis, C	1
Sitruk-Ware, R	1
Noble, A	1
Oyelola, OO	1
Creatsas, G; Serfaty, D; Verougstraete, A; Wildemeersch, D	1
Abdel-Aziz, O; Nafea, S; Rahseed, K; Shaarawy, M; Sheiba, M	1
Ory, HW	1
Mishell, DR	1
Archer, DF	1
Andersen, LF; Christiansen, E; Jespersen, J; Madsbad, S; Petersen, KR; Skouby, SO	1
Colau, JC	1
Imthurn, B; Keller, PJ; Merki-Feld, GS	1
Larsson-Cohn, U; Wallentin, L; Zador, G	1
Andersson, SO; Bergström, R; Holmberg, L; Johansson, JE	1
Aro, J	1
Rudy, DR	1
Dubnitskaia, LV; Korsakov, SG; Manuilova, IA	1
Beaumont, JL; Beaumont, V	1
Edhag, O; Eriksson, A; Henriksson, P; Johansson, SE	1
Fotherby, K	1
Crona, N; Enk, L; Lindberg, UB; Silfverstolpe, G	1
Babaian, RJ; Johnson, DE; Swanson, DA; Tenney, D; von Eschenbach, AC; Wishnow, KI	1
Carlsson, S; Colleen, S; Hellsten, S; Holmquist, B; Lindstedt, E; Lundgren, R; Nilsson, T; Pompeius, R; Sundin, T; Wadström, L	1
Henriksson, P; Johansson, SE	1
Drawz, B; Drawz, G; Hoffmann, L; Russbüldt, R	1
Policar, M	1
Alfthan, O; Haapiainen, R; Rannikko, S	1
Hedlund, PO; Jogestrand, T; Rössner, S; Säwe, U	1
Oakley, C; Somerville, J	1
Jönsson, G	1

Reviews

12 review(s) available for ethinyl estradiol and Cardiovascular Diseases

Article	Year
Moving toward an understanding of hormone replacement therapy in adolescent girls: looking through the lens of Turner syndrome. Annals of the New York Academy of Sciences, 2008, Volume: 1135 Topics: Adolescent; Adult; Body Height; Cardiovascular Diseases; Cognition Disorders; Estradiol; Estrogen Replacement Therapy; Estrogens; Ethinyl Estradiol; Female; Humans; Karyotyping; Phenotype; Pregnancy; Turner Syndrome	2008
Hormone replacement therapy: optimising the dose and route of administration. Drugs & aging, 2002, Volume: 19, Issue:11 Topics: Administration, Cutaneous; Adult; Aged; Cardiovascular Diseases; Drug Combinations; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hot Flashes; Humans; Medroxyprogesterone; Middle Aged; Osteoporosis, Postmenopausal; Randomized Controlled Trials as Topic	2002
Sex hormone replacement therapy and modulation of vascular function in cardiovascular disease. Expert review of cardiovascular therapy, 2007, Volume: 5, Issue:4 Topics: Animals; Cardiovascular Diseases; Cytoskeleton; Endothelium, Vascular; Estrogen Replacement Therapy; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Extracellular Matrix; Female; Humans; Intracellular Signaling Peptides and Proteins; Menopause; Mitochondria; Postmenopause; Progesterone; Protein Serine-Threonine Kinases; rho-Associated Kinases; Testosterone; Vasodilation	2007
Can 19-nortestosterone derivatives be aromatized in the liver of adult humans? Are there clinical implications? Climacteric : the journal of the International Menopause Society, 2007, Volume: 10, Issue:4 Topics: Androgens; Aromatase; Breast Diseases; Cardiovascular Diseases; Ethinyl Estradiol; Female; Humans; Hyperlipoproteinemias; Liver; Nandrolone; Norethindrone; Norethynodrel; Norpregnenes; Uterine Diseases	2007
[Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)]. Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1994, Volume: 10 Suppl 1 Topics: Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Drug Utilization; Ethinyl Estradiol; Female; Humans; Menstruation Disturbances; Metabolism; Ovulation	1994
[Estrogen-progestin contraception. Disadvantages of estrogen reduction]. Contraception, fertilite, sexualite (1992), 1993, Volume: 21, Issue:6 Topics: Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral, Combined; Endometrial Neoplasms; Ethinyl Estradiol; Female; Fibrocystic Breast Disease; Humans; Incidence; Luteinizing Hormone; Ovarian Cysts; Ovarian Neoplasms; Progestins; Risk Factors; Time Factors; Uterine Hemorrhage	1993
[Side effects of third generation progestins]. Contraception, fertilite, sexualite (1992), 1993, Volume: 21, Issue:4 Topics: Blood Coagulation; Cardiovascular Diseases; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Patient Acceptance of Health Care; Progesterone Congeners; Risk Factors; Triglycerides	1993
Cardiovascular safety of oral contraceptives. What has changed in the last decade? Contraception, 1998, Volume: 58, Issue:3 Suppl Topics: Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral; Ethinyl Estradiol; Female; Hemorrhage; Humans; Myocardial Infarction; Risk Factors; Thromboembolism	1998
Cardiovascular risks: perception versus reality. Contraception, 1999, Volume: 59, Issue:1 Suppl Topics: Adolescent; Adult; Age Factors; Cardiovascular Diseases; Cerebrovascular Disorders; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Embolism; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Myocardial Infarction; Risk Factors; Smoking; Thrombosis	1999
Alesse: leading the shift to 20 microg. American journal of obstetrics and gynecology, 1999, Volume: 181, Issue:5 Pt 2 Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol Congeners; Ethinyl Estradiol; Humans; Levonorgestrel	1999
[Contraception]. Gynecologie, obstetrique & fertilite, 2000, Volume: 28, Issue:6 Topics: Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Contraindications; Desogestrel; Drug Interactions; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Myocardial Infarction; Progestins; Risk Factors; Stroke; Venous Thrombosis; Vinyl Compounds	2000
Oral contraceptives, lipids and cardiovascular disease. Contraception, 1985, Volume: 31, Issue:4 Topics: Adult; Alcohol Drinking; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Desogestrel; Diabetes Mellitus, Type 2; Dietary Carbohydrates; Ethinyl Estradiol; Female; Humans; Hyperlipidemias; Hyperthyroidism; Lipids; Norpregnenes; Obesity; Physical Exertion; Risk; Smoking	1985

Trials

28 trial(s) available for ethinyl estradiol and Cardiovascular Diseases

Article	Year
The effects of different therapeutic modalities on cardiovascular risk factors in women with polycystıc ovary syndrome: A randomızed controlled study. Taiwanese journal of obstetrics & gynecology, 2018, Volume: 57, Issue:3 Topics: Adult; Androstenes; Apolipoproteins B; Blood Glucose; C-Reactive Protein; Cardiovascular Diseases; Drug Therapy, Combination; Ethinyl Estradiol; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metabolic Syndrome; Metformin; Mineralocorticoid Receptor Antagonists; Peptide Fragments; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Young Adult	2018
Androgens drive microvascular endothelial dysfunction in women with polycystic ovary syndrome: role of the endothelin B receptor. The Journal of physiology, 2019, Volume: 597, Issue:11 Topics: Adult; Androgens; Cardiovascular Diseases; Dihydrotestosterone; Endothelin-1; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Microvessels; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Receptor, Endothelin B; Skin; Vascular Endothelial Growth Factor A; Vasodilation; Young Adult	2019
Effects of drospirenone-ethinylestradiol and/or metformin on CD4(+)CD28(null) T lymphocytes frequency in women with hyperinsulinemia having polycystic ovary syndrome: a randomized clinical trial. Reproductive sciences (Thousand Oaks, Calif.), 2013, Volume: 20, Issue:12 Topics: Adolescent; Adult; Analysis of Variance; Androstenes; Cardiovascular Diseases; CD28 Antigens; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Chi-Square Distribution; Ethinyl Estradiol; Female; Humans; Hyperinsulinism; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Reproductive Control Agents; Risk Factors; Rome; Time Factors; Treatment Outcome; Young Adult	2013
Berberine and monacolin effects on the cardiovascular risk profile of women with oestroprogestin-induced hypercholesterolemia. High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension, 2014, Volume: 21, Issue:3 Topics: Adult; Anticholesteremic Agents; Berberine; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Dietary Supplements; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypercholesterolemia; Lipid Metabolism; Lovastatin; Norpregnenes; Pilot Projects; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Treatment Outcome	2014
Oral contraceptives versus physical exercise on cardiovascular and metabolic risk factors in women with polycystic ovary syndrome: a randomized controlled trial. Clinical endocrinology, 2016, Volume: 85, Issue:5 Topics: Adult; Androstenes; Cardiovascular Diseases; Carotid Intima-Media Thickness; Contraceptives, Oral; Ethinyl Estradiol; Exercise; Female; Humans; Hyperandrogenism; Metabolic Diseases; Polycystic Ovary Syndrome; Risk Factors; Young Adult	2016
Comparison of combined hormonal vaginal ring and low dose combined oral hormonal pill for the treatment of idiopathic chronic pelvic pain: a randomised trial. European journal of obstetrics, gynecology, and reproductive biology, 2016, Volume: 207 Topics: Adolescent; Adult; Cardiovascular Diseases; Chronic Pain; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Delayed-Action Preparations; Desogestrel; Ethinyl Estradiol; Female; Follow-Up Studies; Humans; India; Levonorgestrel; Medication Adherence; Middle Aged; Nausea; Patient Satisfaction; Pelvic Pain; Risk; Young Adult	2016
Polycystic ovary syndrome and cardiovascular risk in young patients treated with drospirenone-ethinylestradiol or contraceptive vaginal ring. A prospective, randomized, pilot study. Fertility and sterility, 2010, Volume: 94, Issue:4 Topics: Adult; Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Cardiovascular Physiological Phenomena; Contraception; Contraceptive Devices, Female; Ethinyl Estradiol; Female; Humans; Insulin; Ovary; Pilot Projects; Polycystic Ovary Syndrome; Regional Blood Flow; Risk Factors; Ultrasonography; Young Adult	2010
Comparison of effects of 3 mg drospirenone plus 20 μg ethinyl estradiol alone or combined with metformin or cyproterone acetate on classic metabolic cardiovascular risk factors in nonobese women with polycystic ovary syndrome. Fertility and sterility, 2010, Volume: 94, Issue:5 Topics: Administration, Oral; Adolescent; Adult; Androgens; Androstenes; Blood Pressure; Cardiovascular Diseases; Cyproterone; Dose-Response Relationship, Drug; Drug Therapy, Combination; Estrogens; Ethinyl Estradiol; Female; Glucose; Humans; Hypoglycemic Agents; Insulin; Lipids; Metformin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Young Adult	2010
Drospirenone/ethinyl estradiol versus rosiglitazone treatment in overweight adolescents with polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors. The Journal of clinical endocrinology and metabolism, 2011, Volume: 96, Issue:5 Topics: Adolescent; Adrenocorticotropic Hormone; Androstenes; Body Composition; Cardiovascular Diseases; Double-Blind Method; Ethinyl Estradiol; Female; Glucose Clamp Technique; Glucose Tolerance Test; Hemodynamics; Hormones; Humans; Hyperandrogenism; Hypoglycemic Agents; Insulin Resistance; Menstrual Cycle; Mineralocorticoid Receptor Antagonists; Overweight; Polycystic Ovary Syndrome; Risk Factors; Rosiglitazone; Stimulation, Chemical; Thiazolidinediones	2011
The effects of 2 mg chlormadinone acetate/30 mcg ethinylestradiol, alone or combined with spironolactone, on cardiovascular risk markers in women with polycystic ovary syndrome. Contraception, 2012, Volume: 86, Issue:3 Topics: Adult; Blood Glucose; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Carotid Arteries; Carotid Intima-Media Thickness; Chlormadinone Acetate; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Drug Therapy, Combination; Ethinyl Estradiol; Female; Humans; Insulin; Mineralocorticoid Receptor Antagonists; Polycystic Ovary Syndrome; Risk Factors; Sex Hormone-Binding Globulin; Spironolactone; Testosterone; Triglycerides; Vasodilation	2012
Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome. European journal of endocrinology, 2005, Volume: 152, Issue:2 Topics: Adult; Androgen Antagonists; Cardiovascular Diseases; Cholesterol; Cyproterone Acetate; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Metformin; Obesity; Polycystic Ovary Syndrome; Treatment Outcome	2005
Comparison of ethinyl-estradiol plus cyproterone acetate versus metformin effects on classic metabolic cardiovascular risk factors in women with the polycystic ovary syndrome. The Journal of clinical endocrinology and metabolism, 2007, Volume: 92, Issue:7 Topics: Administration, Oral; Adult; Androgen Antagonists; Androgens; Blood Glucose; Cardiovascular Diseases; Cyproterone Acetate; Drug Combinations; Dyslipidemias; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Lipids; Metformin; Polycystic Ovary Syndrome; Risk Factors	2007
Combined continuous ethinyl estradiol/norethindrone acetate does not improve forearm blood flow in postmenopausal women at risk for cardiovascular events: a pilot study. Journal of women's health (2002), 2007, Volume: 16, Issue:7 Topics: Aged; C-Reactive Protein; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Cross-Over Studies; Double-Blind Method; Drug Administration Schedule; Endothelin-1; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Forearm; Humans; Middle Aged; Norethindrone; Pilot Projects; Plasminogen Activator Inhibitor 1; Postmenopause; Regional Blood Flow; Treatment Outcome; Vascular Cell Adhesion Molecule-1; Women's Health	2007
The 150/30 formulation. Experience in the United Kingdom. The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl Topics: Adult; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Risk; Smoking; Stereoisomerism; United Kingdom	1983
Clinical experience with a low-dose contraceptive agent. European studies. The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl Topics: Adolescent; Adult; Amenorrhea; Body Weight; Cardiovascular Diseases; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Middle Aged; Norgestrel; Pregnancy; Stereoisomerism	1983
Effect of low-dose oral triphasic contraceptives on blood viscosity, coagulation and lipid metabolism. Contraception, 1995, Volume: 52, Issue:3 Topics: Adolescent; Adult; Blood Coagulation; Blood Viscosity; Cardiovascular Diseases; Contraceptives, Oral, Combined; Erythrocyte Deformability; Ethinyl Estradiol; Female; Humans; Lipids; Norpregnenes; Regression Analysis; Risk Factors	1995
Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives. Contraception, 1993, Volume: 47, Issue:5 Topics: Adult; Analysis of Variance; Apolipoprotein A-I; Apolipoproteins; Apolipoproteins B; Blood Pressure; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Medroxyprogesterone Acetate; Nigeria; Norgestrel; Risk Factors	1993
The cardiovascular safety of triphasic contraceptive steroids. Contraception, 1997, Volume: 56, Issue:3 Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Estradiol Congeners; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoprotein(a); Nitric Oxide; P-Selectin; Progesterone Congeners	1997
Metabolic and fibrinolytic response to changed insulin sensitivity in users of oral contraceptives. Contraception, 1999, Volume: 60, Issue:6 Topics: Adult; Antibodies, Monoclonal; Blood Glucose; C-Peptide; Cardiovascular Diseases; Contraceptives, Oral, Synthetic; Diabetes Mellitus, Type 2; Enzyme-Linked Immunosorbent Assay; Ethinyl Estradiol; Female; Fibrinolysis; Glucose Tolerance Test; Humans; Insulin; Insulin Resistance; Norgestrel; Plasminogen Activator Inhibitor 1; Prospective Studies; Tissue Plasminogen Activator; Triglycerides	1999
Plasma lipids and high density lipoproteins during oral contraception with different combinations of ethinyl estradiol and levonorgestrel. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1979, Volume: 11, Issue:7 Topics: Adult; Cardiovascular Diseases; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipoproteins, HDL; Norgestrel; Phospholipids; Pregnancy; Triglycerides	1979
Primary orchiectomy versus estrogen therapy in advanced prostatic cancer--a randomized study: results after 7 to 10 years of followup. The Journal of urology, 1991, Volume: 145, Issue:3 Topics: Aged; Cardiovascular Diseases; Estradiol; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Orchiectomy; Polymers; Prostatic Neoplasms; Survival Rate; Time Factors	1991
Cardiovascular and all-cause mortality in prostatic cancer patients treated with estrogens or orchiectomy as compared to the standard population. The Prostate, 1991, Volume: 18, Issue:2 Topics: Aged; Aged, 80 and over; Cardiovascular Diseases; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Finland; Humans; Male; Middle Aged; Orchiectomy; Prospective Studies; Prostatic Neoplasms	1991
Patients at high risk of cardiovascular complications in oestrogen treatment of prostatic cancer. British journal of urology, 1989, Volume: 63, Issue:2 Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Orchiectomy; Predictive Value of Tests; Prospective Studies; Prostatic Neoplasms; Random Allocation; Risk Factors	1989
A comparison of the effects of ethinyl estradiol and estradiol valerate on serum and lipoprotein lipids. Maturitas, 1988, Volume: 10, Issue:4 Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Estradiol; Ethinyl Estradiol; Female; Humans; Lipids; Lipoproteins; Lipoproteins, VLDL; Menopause; Middle Aged; Risk Factors; Triglycerides	1988
Medical castration using megestrol acetate and minidose estrogen. Urology, 1988, Volume: 31, Issue:5 Topics: Adenocarcinoma; Administration, Oral; Aged; Aged, 80 and over; Cardiovascular Diseases; Clinical Trials as Topic; Diethylstilbestrol; Drug Combinations; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Humans; Lymphatic Metastasis; Male; Megestrol; Megestrol Acetate; Middle Aged; Orchiectomy; Prostatic Neoplasms; Time Factors	1988
Cardiovascular complications of estrogen therapy for nondisseminated prostatic carcinoma. A preliminary report from a randomized multicenter study. Scandinavian journal of urology and nephrology, 1986, Volume: 20, Issue:2 Topics: Aged; Cardiovascular Diseases; Clinical Trials as Topic; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estramustine; Ethinyl Estradiol; Humans; Male; Middle Aged; Nitrogen Mustard Compounds; Prospective Studies; Prostatic Neoplasms; Random Allocation	1986
Prediction of cardiovascular complications in patients with prostatic cancer treated with estrogen. American journal of epidemiology, 1987, Volume: 125, Issue:6 Topics: Aged; Cardiovascular Diseases; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Humans; Male; Orchiectomy; Prospective Studies; Prostatic Neoplasms; Random Allocation; Risk	1987
Comparative study of the effects of two once-a-month injectable contraceptives (Cyclofem and Mesigyna) and one oral contraceptive (Ortho-Novum 1/35) on coagulation and fibrinolysis. Contraception, 2003, Volume: 68, Issue:3 Topics: Adolescent; Adult; Antithrombins; Blood Coagulation; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Factor VII; Factor X; Female; Fibrinogen; Fibrinolysis; Hemoglobins; Humans; Injections; Medroxyprogesterone Acetate; Mestranol; Norethindrone; Partial Thromboplastin Time; Plasminogen; Plasminogen Inactivators; Platelet Count; Protein C; Prothrombin	2003

Other Studies

38 other study(ies) available for ethinyl estradiol and Cardiovascular Diseases

Article	Year
Ameliorative effect of nicotine exposure on insulin resistance is accompanied by decreased cardiac glycogen synthase kinase-3 and plasminogen activator inhibitor-1 during oral oestrogen-progestin therapy. Archives of physiology and biochemistry, 2018, Volume: 124, Issue:2 Topics: Administration, Oral; Aldosterone; Animals; Biomarkers; Cardiovascular Diseases; Contraceptives, Oral, Combined; Corticosterone; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Glycogen Synthase Kinase 3; Heart; Insulin; Insulin Resistance; Insulin Secretion; Insulin-Secreting Cells; Levonorgestrel; Myocardium; Nicotine; Nicotinic Agonists; Plasminogen Activator Inhibitor 1; Prediabetic State; Random Allocation; Rats, Wistar	2018
Risk-Benefit Assessment of Ethinylestradiol Using a Physiologically Based Pharmacokinetic Modeling Approach. Clinical pharmacology and therapeutics, 2018, Volume: 104, Issue:6 Topics: Biotransformation; Cardiovascular Diseases; Computer Simulation; Contraceptive Effectiveness; Contraceptives, Oral, Hormonal; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inducers; Cytochrome P-450 CYP3A Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Ethinyl Estradiol; Female; Humans; Liver; Menstrual Cycle; Models, Biological; Risk Assessment; Risk Factors	2018
Combined hormonal contraceptives and the risk of venous and arterial thromboembolism and cardiovascular death: misuse of automated databases. The journal of family planning and reproductive health care, 2013, Volume: 39, Issue:2 Topics: Androstenes; Bias; Cardiovascular Diseases; Confounding Factors, Epidemiologic; Contraceptives, Oral, Combined; Data Interpretation, Statistical; Databases, Factual; Ethinyl Estradiol; Female; Humans; Risk Factors; Thromboembolism; Venous Thromboembolism	2013
Low-dose estrogen and drospirenone combination: effects on metabolism and endothelial function in postmenopausal women with metabolic syndrome. Clinical and experimental obstetrics & gynecology, 2013, Volume: 40, Issue:2 Topics: Androstenes; Blood Pressure; Brachial Artery; Cardiovascular Diseases; Carotid Artery, Common; Carotid Intima-Media Thickness; Cholesterol; Endothelium, Vascular; Estrogens; Ethinyl Estradiol; Female; Humans; Metabolic Syndrome; Middle Aged; Postmenopause; Risk Factors; Triglycerides; Vasodilation	2013
How medical treatment affects mean platelet volume as a cardiovascular risk marker in polycystic ovary syndrome? Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis, 2015, Volume: 26, Issue:8 Topics: Adolescent; Adult; Androgen Antagonists; Biomarkers; Blood Platelets; Body Mass Index; C-Reactive Protein; Cardiovascular Diseases; Case-Control Studies; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Hypoglycemic Agents; Insulin Resistance; Leukocyte Count; Mean Platelet Volume; Metformin; Polycystic Ovary Syndrome; Regression Analysis; Treatment Outcome	2015
Cardiovascular risk in Egyptian healthy consumers of different types of combined oral contraceptives pills: A comparative study. Endocrine, 2015, Volume: 49, Issue:3 Topics: Adiponectin; Adipose Tissue; Adult; Androstenes; Anthropometry; Cardiovascular Diseases; Chemistry, Pharmaceutical; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cross-Sectional Studies; Drug Combinations; Egypt; Ethinyl Estradiol; Female; Humans; Leptin; Levonorgestrel; Norpregnenes; Resistin; Risk Factors	2015
Oral contraceptive use among women aged 15 to 49: Results from the Canadian Health Measures Survey. Health reports, 2015, Volume: 26, Issue:10 Topics: Adolescent; Adult; Canada; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Contraceptives, Oral, Combined; Dose-Response Relationship, Drug; Drug Utilization; Ethinyl Estradiol; Female; Health Surveys; Humans; Middle Aged; Population Surveillance; Progestins; Public Health; Risk Factors; Young Adult	2015
Cardiovascular risks associated with the use of drospirenone-containing combined oral contraceptives. Contraception, 2016, Volume: 93, Issue:5 Topics: Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral, Combined; Ethinyl Estradiol; Europe; Female; Follow-Up Studies; Humans; Incidence; Levonorgestrel; Longitudinal Studies; Mineralocorticoid Receptor Antagonists; Patient Reported Outcome Measures; Pharmacovigilance; Progestins; Proportional Hazards Models; Risk Factors	2016
Risk factors of cardiovascular disease among the oral contraceptive users in Kermanshah City of Iran. JPMA. The Journal of the Pakistan Medical Association, 2008, Volume: 58, Issue:8 Topics: Adult; Cardiovascular Diseases; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Iran; Levonorgestrel; Prevalence; Risk Factors	2008
Increased thrombin-activatable fibrinolysis inhibitor antigen levels as a clue for prothrombotic state in polycystic ovary syndrome. Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 2008, Volume: 24, Issue:9 Topics: Adult; Antigens; Carboxypeptidase B2; Cardiovascular Diseases; Case-Control Studies; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Humans; Models, Biological; Polycystic Ovary Syndrome; Risk Factors; Thrombosis; Up-Regulation; Young Adult	2008
Ethinyl estradiol-to-desogestrel ratio impacts endothelial function in young women. Contraception, 2009, Volume: 79, Issue:1 Topics: Adolescent; Adult; Cardiovascular Diseases; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Desogestrel; Dose-Response Relationship, Drug; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Risk Factors; Vasodilation; Young Adult	2009
International Active Surveillance Study of Women Taking Oral Contraceptives (INAS-OC Study). BMC medical research methodology, 2009, Nov-18, Volume: 9 Topics: Adolescent; Adult; Androstenes; Cardiovascular Diseases; Cohort Studies; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Internationality; Population Surveillance; Progestins; Research Design; Young Adult	2009
Contraceptive options for women in selected circumstances. Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5 Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult	2010
Alteration of cardiovascular risk parameters in women with polycystic ovary syndrome who were prescribed to ethinyl estradiol-cyproterone acetate. Archives of gynecology and obstetrics, 2011, Volume: 284, Issue:4 Topics: Blood Flow Velocity; Blood Glucose; Brachial Artery; Cardiovascular Diseases; Carotid Intima-Media Thickness; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral, Combined; Cyproterone; Ethinyl Estradiol; Female; Humans; Polycystic Ovary Syndrome; Risk Factors; Testosterone; Triglycerides; Young Adult	2011
Association of estrogen receptor alpha gene polymorphisms with autonomic modulation of heart rate in users and nonusers of oral contraceptives. Contraception, 2013, Volume: 88, Issue:1 Topics: Adult; Autonomic Nervous System; Blood Pressure; Brazil; Cardiovascular Diseases; Contraceptives, Oral, Combined; Desogestrel; Estrogen Receptor alpha; Estrogens; Ethinyl Estradiol; Female; Genetic Association Studies; Heart Rate; Humans; Introns; Levonorgestrel; Norpregnenes; Polymorphism, Single Nucleotide; Progestins; Risk Factors	2013
Combined oral contraceptive containing drospirenone does not modify 24-h ambulatory blood pressure but increases heart rate in healthy young women: prospective study. Contraception, 2013, Volume: 88, Issue:3 Topics: Adolescent; Adult; Androstenes; Blood Pressure; Cardiovascular Diseases; Circadian Rhythm; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Heart Rate; Humans; Hypertension; Young Adult	2013
PRESBYACUSIS. A CLINICAL STUDY. The Journal of laryngology and otology, 1964, Volume: 78 Topics: Aging; Anesthesia; Bendroflumethiazide; Cardiovascular Diseases; Ethinyl Estradiol; Geriatrics; Hearing Disorders; Hearing Loss, Noise-Induced; Hearing Tests; Hot Temperature; Humans; Labyrinth Diseases; Methyltestosterone; Nitrous Oxide; Presbycusis; Smoking; Tinnitus; Vasodilator Agents; Vertigo; Vitamin B Complex	1964
[Hormone replacement therapy and the risk of developing breast cancer]. MMW Fortschritte der Medizin, 2004, Feb-26, Volume: 146, Issue:9 Topics: Breast Neoplasms; Cardiovascular Diseases; Climacteric; Endometrial Neoplasms; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormone Replacement Therapy; Humans; Medroxyprogesterone Acetate; Middle Aged; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Assessment	2004
Advances in oral contraception. An international review of levonorgestrel and ethinyl estradiol. The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl Topics: Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism	1983
Development of the ratio of levonorgestrel, 0.15 mg, to ethinyl estradiol, 0.03 mg. The Journal of reproductive medicine, 1983, Volume: 28, Issue:1 Suppl Topics: Body Weight; Cardiovascular Diseases; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Norgestrel; Stereoisomerism	1983
The influence of treatment with estrogens and estramustine phosphate on platelet aggregation and plasma lipoproteins in non-disseminated prostatic carcinoma. The Journal of urology, 1984, Volume: 132, Issue:5 Topics: Aged; Apolipoproteins; Carcinoma; Cardiovascular Diseases; Cholesterol, HDL; Cholesterol, LDL; Drug Therapy, Combination; Estradiol; Estradiol Congeners; Estramustine; Ethinyl Estradiol; Fatty Acids; Humans; Lipoproteins; Male; Nitrogen Mustard Compounds; Platelet Aggregation; Prostatic Neoplasms; Risk; Thromboembolism; Triglycerides	1984
Progestogens and arterial disease--evidence from the Royal College of General Practitioners' study. American journal of obstetrics and gynecology, 1982, Mar-15, Volume: 142, Issue:6 Pt 2 Topics: Adult; Cardiovascular Diseases; Cholesterol; Cholesterol, HDL; Contraceptives, Oral; Contraceptives, Oral, Synthetic; England; Ethinyl Estradiol; Female; Humans; Levonorgestrel; Lipoproteins, HDL; Norethindrone; Norethindrone Acetate; Norgestrel; Progesterone Congeners; Prospective Studies	1982
Progestogens and cardiovascular reactions associated with oral contraceptives and a comparison of the safety of 50- and 30-microgram oestrogen preparations. British medical journal, 1980, May-10, Volume: 280, Issue:6224 Topics: Cardiovascular Diseases; Contraceptives, Oral; Dose-Response Relationship, Drug; Drug Combinations; Ethinyl Estradiol; Female; Humans; Norethindrone; Norgestrel; Thrombophlebitis	1980
Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet (London, England), 1995, Dec-16, Volume: 346, Issue:8990 Topics: Adult; Cardiovascular Diseases; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Desogestrel; Ethinyl Estradiol; Female; Humans; Incidence; Levonorgestrel; Norpregnenes; Progestins; Risk Factors; Thromboembolism	1995
Relationships between blood pressure, oral contraceptive use and metabolic risk markers for cardiovascular disease. Contraception, 1995, Volume: 52, Issue:3 Topics: Adolescent; Adult; Biomarkers; Blood Glucose; Blood Pressure; C-Peptide; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Desogestrel; Ethinyl Estradiol; Female; Glucose Tolerance Test; Humans; Hypertension; Insulin; Levonorgestrel; Middle Aged; Norethindrone; Risk Factors	1995
Postmenopausal hormone replacement therapy. BMJ (Clinical research ed.), 1993, Jan-23, Volume: 306, Issue:6872 Topics: Aged; Cardiovascular Diseases; Estradiol; Estrogen Replacement Therapy; Ethinyl Estradiol; Female; Humans; Middle Aged	1993
European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12". International journal of fertility and menopausal studies, 1995, Volume: 40 Suppl 2 Topics: Adult; Aging; Cardiovascular Diseases; Contraception; Contraceptives, Oral; Data Collection; Desogestrel; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Estradiol Congeners; Ethinyl Estradiol; Europe; Female; Humans; Levonorgestrel; Norgestrel; Norpregnenes; Progesterone; Progesterone Congeners; Risk Factors; Smoking; Surveys and Questionnaires	1995
The effect of the menstrual cycle and of ethinylestradiol on nitric oxide, endothelin-1 and homocysteine plasma levels. Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 2000, Volume: 32, Issue:7 Topics: Adult; Cardiovascular Diseases; Endothelin-1; Ethinyl Estradiol; Female; Homocysteine; Humans; Menstrual Cycle; Nitric Oxide; Risk Factors; Vasodilation	2000
Hormone replacement therapy. How to select the best preparation and regimen. Postgraduate medicine, 1990, Volume: 88, Issue:8 Topics: Cardiovascular Diseases; Climacteric; Contraindications; Estradiol; Estrogen Replacement Therapy; Estrogens, Conjugated (USP); Estrone; Ethinyl Estradiol; Female; Humans; Osteoporosis, Postmenopausal	1990
[Changes in arterial blood pressure of women using hormonal contraceptives in relation to their cardiovascular history]. Akusherstvo i ginekologiia, 1989, Issue:7 Topics: Adult; Blood Pressure; Cardiovascular Diseases; Chlormadinone Acetate; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Disease Susceptibility; Drug Combinations; Ethinyl Estradiol; Ethinyl Estradiol-Norgestrel Combination; Female; Humans; Hypertension; Middle Aged; Norethindrone; Norgestrel; Risk Factors	1989
[Vascular risk of oral contraceptive agents: realities and mechanisms. II. Mechanisms of vascular accidents: their prevention]. Presse medicale (Paris, France : 1983), 1989, Jun-24, Volume: 18, Issue:25 Topics: Adult; Age Factors; Antibodies; Arteriosclerosis; Blood Coagulation; Cardiovascular Diseases; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Hypertension; Lipids; Risk Factors; Smoking	1989
[Experiences in the treatment of advanced prostatic cancer using Turisteron with special reference to cardiovascular complications]. Zeitschrift fur Urologie und Nephrologie, 1987, Volume: 80, Issue:3 Topics: Adenocarcinoma; Aged; Aged, 80 and over; Carcinoma; Cardiovascular Diseases; Ethinyl Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Risk	1987
Oral contraception, 1986. Endocrinology and pharmacology. A panel discussion. The Journal of reproductive medicine, 1986, Volume: 31, Issue:6 Suppl Topics: Adult; Animals; Breast Neoplasms; Cardiovascular Diseases; Cholesterol, HDL; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Ethinyl Estradiol; Female; Genital Neoplasms, Female; Humans; Mestranol; Middle Aged; Norethindrone; Norgestrel; Rats; Risk	1986
Clinical experience with multiphasic oral contraceptives. The Journal of reproductive medicine, 1986, Volume: 31, Issue:9 Suppl Topics: Adult; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptives, Oral, Combined; Ethinyl Estradiol; Female; Humans; Lipid Metabolism; Middle Aged; Norethindrone; Progesterone Congeners; Substance Withdrawal Syndrome; Uterine Hemorrhage; Virilism	1986
Comparison of primary orchiectomy with oestrogen therapy in advanced prostatic cancer. A 2-year follow-up report of a national, prospective prostatic cancer study. British journal of urology, 1986, Volume: 58, Issue:5 Topics: Cardiovascular Diseases; Estradiol; Estradiol Congeners; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Neoplasm Metastasis; Orchiectomy; Prognosis; Prostatic Neoplasms	1986
Treatment of prostatic cancer: effects on serum lipoproteins and the cardiovascular system. The Journal of urology, 1985, Volume: 133, Issue:1 Topics: Aged; Blood Pressure; Blood Volume Determination; Cardiography, Impedance; Cardiovascular Diseases; Castration; Combined Modality Therapy; Estradiol; Estradiol Congeners; Estramustine; Ethinyl Estradiol; Exercise Test; Fat Emulsions, Intravenous; Humans; Lipoproteins; Male; Middle Aged; Prostatic Neoplasms; Time Factors	1985
Oral contraceptives and progressive pulmonary vascular disease. Lancet (London, England), 1968, Apr-27, Volume: 1, Issue:7548 Topics: Adult; Cardiovascular Diseases; Contraceptives, Oral; Ethinyl Estradiol; Female; Heart Defects, Congenital; Humans; Lynestrenol; Mestranol; Norethindrone; Norethynodrel; Pregnancy; Pulmonary Circulation	1968
Treatment of prostatic carcinoma with polyestradiol phosphate combined with ethinylestradiol. Scandinavian journal of urology and nephrology, 1971, Volume: 5, Issue:2 Topics: Adult; Age Factors; Aged; Androgens; Carcinoma; Cardiovascular Diseases; Estrogens; Ethinyl Estradiol; Follow-Up Studies; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Testis; Urinary Diversion; Urination Disorders	1971